• About us
• Contact

Advertisement

Product › Details

Tarpeyo® (delayed release capsules)

	Status	2024-06-04 sales existent
	Organisation	Calliditas Therapeutics AB (Nasdaq Stockholm: CALTX)
	Group	Asahi Kasei (Group)

Record changed: 2024-06-04

Advertisement

More documents for pharmaceutical

• [1] Lonza Group AG. (5/15/25). "Press Release: Lonza Appoints Andreas Bohrer as Chief Legal & Corporate Affairs Officer". Basel....
• [2] Agilent Technologies Inc.. (5/14/25). "Press Release: Agilent Partners Ubix Therapeutics to Advance Transformative Cancer Research in South Korea". Seoul....
• [3] Regeneron Pharmaceuticals, Inc.. (4/22/25). "Press Release: Regeneron Announces New Investment in Manufacturing of its Industry-Leading Biologic Medicines". Tarrytown, NY....
• [4] Earendil Labs. (4/17/25). "Press Release: Earendil Labs Announces Worldwide Exclusive License Agreement with Sanofi for Next-Generation Bispecific Antibodies for Autoimmune and Inflammatory Bowel Diseases". Middletown, DE....
• [5] Glycomine, Inc.. (4/16/25). "Press Release: Glycomine Announces $115 Million Series C Financing to Advance Lead Drug Candidate, GLM101, into a Phase 2b Clinical Trial for PMM2-CDG". San Carlos, CA....
• [6] ExpreS2ion Biotech Holding AB. (4/15/25). "Press Release: ExpreS2ion Signs Letter of Intent with WuXi Vaccines to Initiate Technology Evaluation of ExpreS2ion’s Proprietary Production Platform ExpreS2". Hørsholm....
• [7] Chromatin Bioscience Ltd.. (4/14/25). "Press Release: Chromatin Bioscience Signs Collaboration Agreement with Astellas". Edinburgh....
• [8] Bayer AG. (3/26/25). "Press Release: Bayer and Puhe BioPharma Enter into Global License Agreement for Clinical Phase I PRMT5 inhibitor [Not intended for U.S. and UK Media]". Berlin & Beijing....
• [9] Genmab A/S. (3/22/25). "Press Release: Genmab to Vigorously Defend Alleged Claims of Trade Secret Misappropriation by AbbVie Inc.". Copenhagen....
• [10] AstraZeneca plc. (3/21/25). "Press Release: AstraZeneca to Invest $2.5 Billion in New Global Strategic R&D Centre, Biotech Agreements and Manufacturing in Beijing"....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

» top

» Imprint  |  » Data Privacy  |  » Contact  |  The use of this website requires to accept the » Disclaimer!   |  A project of [iito] Business Intelligence © 2002-2025. Made in Germany.